EyePoint Pharmaceuticals Inc (PSDV):企業の製品パイプライン分析2018

◆英語タイトル:EyePoint Pharmaceuticals Inc (PSDV) - Product Pipeline Analysis, 2018 Update
◆商品コード:DATA904C7710
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD750 ⇒換算¥103,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD1,500 ⇒換算¥207,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥310,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
EyePoint Pharmaceuticals Inc (EyePoint), formerly pSivida Corp, is a biopharmaceutical company that provides development of miniaturized, sustained-release drug delivery products and technologies. The company offers products such as iluvien, retisert and durasert, among others. Its durasert is an injectable, miniaturized, sustained-release drug delivery system, used for the treatment of chronic diseases of the back of the eye. EyePoint’s iluvien is an injectable, non-erodible, intravitreal implant for the treatment of DME. The company provides drug delivery products and technologies to treat serious, debilitating diseases of the eye that can lead to blindness. It operates in the US and the UK. pSivida is headquartered in Watertown, Massachusetts, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company EyePoint Pharmaceuticals Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
EyePoint Pharmaceuticals Inc Company Overview 5
EyePoint Pharmaceuticals Inc Company Snapshot 5
EyePoint Pharmaceuticals Inc Pipeline Products and Ongoing Clinical Trials Overview 5
EyePoint Pharmaceuticals Inc – Pipeline Analysis Overview 7
EyePoint Pharmaceuticals Inc – Key Facts 7
EyePoint Pharmaceuticals Inc – Major Products and Services 8
EyePoint Pharmaceuticals Inc Pipeline Products by Development Stage 9
EyePoint Pharmaceuticals Inc Ongoing Clinical Trials by Trial Status 11
EyePoint Pharmaceuticals Inc Pipeline Products Overview 12
Durasert – Back Of Eye Disease 12
Durasert – Back Of Eye Disease Product Overview 12
Durasert – Front Of Eye Disease 13
Durasert – Front Of Eye Disease Product Overview 13
Durasert – Knee Osteoarthritis 14
Durasert – Knee Osteoarthritis Product Overview 14
Durasert Latanoprost Implant 15
Durasert Latanoprost Implant Product Overview 15
DURASERT With TKI – Wet AMD 16
DURASERT With TKI – Wet AMD Product Overview 16
Next Gen Duraset – Posterior Segment Uveitis 17
Next Gen Duraset – Posterior Segment Uveitis Product Overview 17
Tethadur System 18
Tethadur System Product Overview 18
YUTIQ 19
YUTIQ Product Overview 19
YUTIQ Clinical Trial 20
EyePoint Pharmaceuticals Inc – Key Competitors 21
EyePoint Pharmaceuticals Inc – Key Employees 22
EyePoint Pharmaceuticals Inc – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 24
EyePoint Pharmaceuticals Inc, Recent Developments 24
Jul 11, 2018: EyePoint Pharmaceuticals Announces Data Highlighting YUTIQ for Posterior Segment Uveitis to be Presented at the 36th Annual Scientific Meeting of the American Society of Retina Specialists 24
Jul 10, 2018: BioArctic receives regulatory approval in Finland for Phase 1/2 study in patients with Complete Spinal Cord Injury 24
Jun 26, 2018: EyePoint Pharmaceuticals Names Goran Ando As Board Director 25
May 16, 2018: EyePoint Pharmaceuticals Announces Appointment of Leonard Blum as Executive Vice President and General Manager, U.S. 25
May 08, 2018: EyePoint Pharmaceuticals Reports Fiscal Third Quarter 2018 Results 26
Apr 18, 2018: EyePoint Pharmaceuticals YUTIQ for Posterior Segment Uveitis to be Presented at the 2018 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting 27
Mar 19, 2018: pSivida Announces FDA Acceptance For Filing of New Drug Application (NDA) for Durasert Three-Year Treatment for Posterior Segment Uveitis 27
Feb 07, 2018: pSivida Reports Second Quarter FY2018 Results; Continues to Achieve Milestones and Timelines 28
Feb 07, 2018: pSivida’s Second Phase 3 Study for Durasert Three-year Treatment for Posterior Segment Uveitis Maintains Positive Efficacy and Safety Profile at 12 Months 29
Jan 08, 2018: pSivida Submits New Drug Application for Durasert Three-Year Treatment for Posterior Segment Uveitis to the U.S. FDA 29
Appendix 30
Methodology 30
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
EyePoint Pharmaceuticals Inc Pipeline Products and Ongoing Clinical Trials Overview 5
EyePoint Pharmaceuticals Inc Pipeline Products by Equipment Type 6
EyePoint Pharmaceuticals Inc Pipeline Products by Indication 6
EyePoint Pharmaceuticals Inc Ongoing Clinical Trials by Trial Status 6
EyePoint Pharmaceuticals Inc, Key Facts 7
EyePoint Pharmaceuticals Inc, Major Products and Services 8
EyePoint Pharmaceuticals Inc Number of Pipeline Products by Development Stage 9
EyePoint Pharmaceuticals Inc Pipeline Products Summary by Development Stage 10
EyePoint Pharmaceuticals Inc Ongoing Clinical Trials by Trial Status 11
EyePoint Pharmaceuticals Inc Ongoing Clinical Trials Summary 11
Durasert - Back Of Eye Disease - Product Status 12
Durasert - Back Of Eye Disease - Product Description 12
Durasert - Front Of Eye Disease - Product Status 13
Durasert - Front Of Eye Disease - Product Description 13
Durasert - Knee Osteoarthritis - Product Status 14
Durasert - Knee Osteoarthritis - Product Description 14
Durasert Latanoprost Implant - Product Status 15
Durasert Latanoprost Implant - Product Description 15
DURASERT With TKI - Wet AMD - Product Status 16
DURASERT With TKI - Wet AMD - Product Description 16
Next Gen Duraset - Posterior Segment Uveitis - Product Status 17
Next Gen Duraset - Posterior Segment Uveitis - Product Description 17
Tethadur System - Product Status 18
Tethadur System - Product Description 18
YUTIQ - Product Status 19
YUTIQ - Product Description 19
YUTIQ - A Multi-center, Controlled, Safety and Efficacy Study of a Fluocinolone Acetonide Intravitreal (FAI) Insert in Subjects with Chronic Non-infectious Uveitis Affecting the Posterior Segment of the Eye 20
YUTIQ - A Phase III, Multi-national, Multi-center, Randomized, Masked, Controlled, Safety and Efficacy Study of a Fluocinolone Acetonide Intravitreal Insert in Subjects with Chronic Non-infectious Uveitis Affecting the Posterior Segment of the Eye 20
EyePoint Pharmaceuticals Inc, Key Employees 22
EyePoint Pharmaceuticals Inc, Subsidiaries 23
Glossary 32

List of Figures
EyePoint Pharmaceuticals Inc Pipeline Products by Equipment Type 6
EyePoint Pharmaceuticals Inc Pipeline Products by Development Stage 9
EyePoint Pharmaceuticals Inc Ongoing Clinical Trials by Trial Status 11

★海外企業調査レポート[EyePoint Pharmaceuticals Inc (PSDV):企業の製品パイプライン分析2018]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • JSC Gazprom Neft:企業の戦略・SWOT・財務情報
    JSC Gazprom Neft - Strategy, SWOT and Corporate Finance Report Summary JSC Gazprom Neft - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Dow Inc (DOW):企業の財務・戦略的SWOT分析
    Dow Inc (DOW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Serco Group plc (SRP):企業の財務・戦略的SWOT分析
    Serco Group plc (SRP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Sunvault Energy Inc:電力:M&Aディール及び事業提携情報
    Summary Sunvault Energy Inc (Sunvault Energy) is a renewable energy company that provides solar energy products and solutions. The company provides products such as solar energy products, renewable energy products, water and sewer equipment, wind power generation equipment, solar power generation eq …
  • Altona Energy Plc:企業の戦略・SWOT・財務分析
    Altona Energy Plc - Strategy, SWOT and Corporate Finance Report Summary Altona Energy Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • JGC Corporation (1963)-エネルギー分野:企業M&A・提携分析
    Summary JGC Corporation (JGC) is an engineering contracting company. It offers engineering, procurement and construction services for various engineering contracts and projects in the areas of oil and gas development, petroleum refining, natural gas processing, petrochemicals, clean energy and power …
  • MedImmune Ltd-製薬・医療分野:企業M&A・提携分析
    Summary MedImmune Ltd (MedImmune), formerly Cambridge Antibody Technology Ltd, is a subsidiary of AstraZeneca Plc, is a research and development company that develops and commercializes small molecule and biologic prescription medicines for the prevention of respiratory tract disease caused by respi …
  • Taiheiyo Cement Corporation:企業の戦略・SWOT・財務分析
    Taiheiyo Cement Corporation - Strategy, SWOT and Corporate Finance Report Summary Taiheiyo Cement Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Medical Depot Inc:医療機器:M&Aディール及び事業提携情報
    Summary Medical Depot Inc (Drive Medical) is a manufacturer and distributor of durable medical equipment. The company provides rollators, walkers, canes and crutches, commodes, bath safety, patient room , wheelchairs, power mobility, beds, pressure prevention, electrotherapy, lifestyle essentials, r …
  • Simcere Pharmaceutical Group-製薬・医療分野:企業M&A・提携分析
    Summary Simcere Pharmaceutical Group (Simcere) is a drug discovery company that manufactures and supplies branded generic and prescription pharmaceutical products. The company offers products in therapeutic areas including anti-tumor, central nervous, anti-infection, cardiovascular, skeletal muscle, …
  • Sherman & Howard LLC:企業の戦略的SWOT分析
    Sherman & Howard LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Town Centre Securities Plc:企業の戦略・SWOT・財務情報
    Town Centre Securities Plc - Strategy, SWOT and Corporate Finance Report Summary Town Centre Securities Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • HSN, Inc.:企業の戦略・SWOT・財務情報
    HSN, Inc. - Strategy, SWOT and Corporate Finance Report Summary HSN, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • TMX Group Ltd (X)
    TMX Group Ltd (X) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • SEAKR Engineering, Inc.:企業の戦略・SWOT・財務情報
    SEAKR Engineering, Inc. - Strategy, SWOT and Corporate Finance Report Summary SEAKR Engineering, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Avedro Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Avedro Inc (Averdro) is a medical device company that manufactures and distributes cross-linking systems and riboflavin ophthalmic products. The company’s products include mosaic systems for PiXL, lasik xtra, and accelerated cross-linking; KXL systems for lasik xtra and accelerated cross-lin …
  • Devon Energy Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Devon Energy Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Devon Energy Corp (Devon Energy) is an independent energy company. The company carries out exploration, development, and production of oil, natural gas and natural gas liquids (NGLs). It has its op …
  • InSphero AG:医療機器:M&Aディール及び事業提携情報
    Summary InSphero AG (InSphero) is a biotechnology company that offers production, culture and assessment of organotypic 3D cell culture models. The company’s product portfolio includes microtissues kits, cytotoxicity assay kits, and microtissue spheroids, among others. Its patented 3D cell culture p …
  • Seven Bank, Ltd.:企業の戦略・SWOT・財務情報
    Seven Bank, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Seven Bank, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • WPPI Energy, Inc.:企業の戦略的SWOT分析
    WPPI Energy, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆